Login
Login     |     Register     |     Recover Username/Password

Jim Birchenough

BMO Capital Markets Corp.

Jim Birchenough is a Managing Director at BMO Capital Markets Corp. and Senior Biotechnology Analyst. He has been covering the U.S. biotechnology sector for 11 years, including 10 years previously at Lehman Brothers and Barclays Capital. Dr. Birchenough is a Canadian-board-certified Primary Care Physician with practice experience in the U.S. and Canada, and also has extensive prior pharmaceutical industry experience as a former Bench Scientist and Pharmaceutical Sales Representative with Merck Frosst.

U.S. Biotech Valuations Appear Attractive Despite Earlier Run
September 17, 2012 - Pharmaceuticals

TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Reports
Semiconductors

Published May 24, 2013

Topics Covered: Semiconductor Capital Equipment - Cloud Computing, Mobile Device Consumer Demand - Semiconductor Inventory Burnoff - Improvement from Cyclical Bottom - Semiconductor Capital Equipment Spending - New Computing Platform Demand
Buy ($175)
Multicap Value Investing

Published May 24, 2013

Topics Covered: Investing in Financial Services - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing
Buy ($175)
Industrial Equipment, Aerospace and Defense

Published May 24, 2013

Topics Covered: Commercial Aviation and Energy Expenditures - Industrial Restructuring - Emerging Markets Penetration - Heightened M&A Activity - Defense Budget Uncertainty - Capital Equipment Technology Investing
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now